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Abstract
Background The association between obesity and albu-
minuria in the general population remains unclear. We
aimed to identify the association between obesity and
albuminuria as well as sex differences regarding the asso-
ciations using several obesity indices, including waist cir-
cumference (WC), body mass index (BMI), and waist-to-
height ratio (WHR).
Methods This study included 3841 subjects (1730 males
and 2111 females; age 20–80 years) who participated in
the Fifth Korea National Health and Nutrition Examination
Survey conducted in 2011. Subjects with hypertension,
diabetes, renal failure, or a malignant tumor and those who
were pregnant or menstruating were excluded. Albumin-
uria was defined as a urinary albumin-to-creatinine
ratio C30 mg/g. Anthropometric parameters were catego-
rized into sex-specific quartiles. Logistic regression models
were used to assess the associations between each anthro-
pometric parameter and albuminuria.
Results All of the obesity indices of the fourth quartile
group of females showed a twofold higher risk for albu-
minuria than the second quartile group, and it was persis-
tently significant after adjusting for age, smoking, and
physical activity. After further adjustment for high blood
pressure and impaired fasting glucose and triglyceride
levels, WC and BMI of the fourth quartile group of females
still showed a significantly higher risk for albuminuria than
the second quartile group (odds ratios 1.96 and 2.24; 95 %
confidence intervals 1.03–3.74 and 1.15–4.37). None of the
associations between albuminuria and the obesity indices
were significant in males.
Conclusion Higher WC and BMI were significantly
associated with the risk of albuminuria among females, but
not males.
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Introduction
Obesity is a major risk factor for cardiovascular disease,
diabetes mellitus, and hypertension [1]. The prevalence of
obesity has increased worldwide. According to Korea
Health Statistics 2011, obesity affects one-third of Korean
adults [2]. Chronic kidney disease (CKD) is also a global
health concern with increasing incidence and prevalence
[3]. Traditional risk factors for CKD include diabetes
mellitus, hypertension, and metabolic syndrome [4], which
are health problems related to obesity. Microalbuminuria is
an early marker of kidney injury and a predictor of end
stage-renal disease (ESRD) and cardiovascular mortality
[5, 6].
Previous studies have suggested that obesity increases
the risk of CKD and albuminuria; however, results have
been inconsistent due to the obesity indices used, con-
founding factors, and the sex ratio of the population. A
longitudinal cohort study from the Framingham Offspring
Study reported that higher body mass index (BMI) is
related to developing CKD [7]. A retrospective case–con-
trol study showed that obesity, as defined by BMI among
both males and females, is linked to an increased risk for
CKD [8]. Another study found an association between
higher BMI and the risk for ESRD in both sexes [9].
However, studies from Singapore and Japan have sug-
gested a sex-specific association between BMI and CKD
[10–12]. They reported a positive correlation between
higher BMI and CKD among males, but not females. In
contrast, Chinese studies have reported that abdominal
obesity is related to CKD or albuminuria among females,
but not males. Lin et al. found that the waist-to-height ratio
(WHR) is associated with CKD in Chinese females,
whereas the association was not significant in males [13].
Furthermore, another Chinese study showed that central
obesity, as measured by waist circumference (WC), indi-
cates a tendency to develop albuminuria independently of
BMI. These findings were most pronounced in females
[14]. Although two other Korean studies demonstrated that
obesity is associated with albuminuria among the general
population and hypertensive adults [15, 16], they did not
consider sex differences between obesity and albuminuria.
These controversies about obesity and renal dysfunction
may be due to differences in ethnicity, sex, obesity indices,
or adjusted covariates. Thus, we conducted this study to
determine the sex-specific associations between various
obesity indices (WC, WHR, and BMI) and albuminuria in
the general Korean population. We used the Fifth Korea
National Health and Nutrition Examination Survey
(KNHANES V-2) data from 2011 and targeted non-dia-
betic and non-hypertensive healthy adults to minimize the
influences of traditional risk factors for CKD.
Methods
Study population
This study was based on data acquired in the KNHANES
V-2. The KNHANES has been conducted periodically
since 1998 to assess the health and nutritional status in the
civilian, non-institutionalized Korean population. The
KNHANES V is a cross-sectional and nationally repre-
sentative survey that was conducted by the Korea Centers
for Disease Control and Prevention (KCDC) from 2010 to
2012. Urine albumin was first measured starting in 2011
(KNHANES V-2), and 3840 households were selected
using a stratified, multistage probability sampling design.
A total of 8518 individuals completed the health interview
and health examination surveys. We included 6308 adults
(age 20–79 years) and excluded subjects who took anti-
hypertensive or antidiabetic medications, those who
reported a history of chronic renal failure or cancer,
females who were pregnant or menstruating during the
health examination, and subjects with missing urine albu-
min data. Finally, 3841 participants (1730 males and 2111
females) were selected as our study population.
KNHANES was conducted in accordance with the
Ethical Principles for Medical Research Involving Human
Subjects. All of the participants provided informed consent
prior to participation in the study. This study was approved
by the Institutional Review Board of Hallym University
Sacred Heart Hospital (IRB approval number 2013-I075).
Data collection and measurements
Data were collected through standardized health exami-
nations conducted in specially equipped mobile examina-
tion centers and via face-to-face interviews inside
households. The health survey sequence involved intake,
receipt of written informed consent, anthropometric mea-
surements, blood sampling, and completion of a question-
naire survey. A standardized questionnaire regarding age,
socioeconomic characteristics, medical history, drug use,
smoking habit and other lifestyle risk factors was prepared.
Anthropometric data were measured according to stan-
dardized guidelines. Height and weight were obtained
using standardized techniques and equipment. Height was
measured to the nearest 0.1 cm using a portable stan-
diometer (Seriter, Bismarck, ND, USA). Weight was
measured to the nearest 0.1 kg using a Giant-150 N cali-
brated balance-beam scale (Hana, Seoul, Korea). BMI was
calculated by dividing weight by the square of height (kg/
m2). WC was measured to the nearest 0.1 cm during
exhalation, using a measuring tape (SECA 200, SECA,
Chino, CA, USA) at the horizontal plane midway between
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the inferior costal margin and the iliac crest at the mid-
axillary line. The WHR was calculated as WC in cm
divided by height in cm. Systolic and diastolic blood
pressure (BP) was measured by standard methods using a
sphygmomanometer (Baumanometer; Baum, Copiague,
NY, USA) with the patient in the sitting position after a
5-min rest period. Three measurements were obtained with
a 30-s interval. The mean of the second and third mea-
surements was used for analysis. Pulse pressure was cal-
culated as the difference between systolic and diastolic BP.
Blood samples were collected in the morning after at least
an 8-h fast, and single-spot urine specimens were collected
from the first morning void. Analysis of fasting plasma
glucose and serum total cholesterol, triglyceride, low-
density lipoprotein cholesterol and high-density lipoprotein
cholesterol levels was performed with a Hitachi Automatic
Analyzer 7600 (Hitachi, Tokyo, Japan). Smoking status
was classified according to three categories of never smo-
ker, former smoker, and current smoker. Alcohol con-
sumption was categorized into three groups of never
drinker, former drinker, and current drinker. Physical
activity was defined as[150 min of moderate intensity
activity or 60 min of vigorous intensity activity per week.
Obesity indices and albuminuria
We divided the subjects into four groups based on sex-specific
quartiles (I–IV) of the obesity indices (BMI, WC, and WHR).
The quartile criteria for males and females were as follows.
For males, BMI: 14.4 B I\ 21.8 kg/m2, 21.8 B II\ 23.9
kg/m2, 23.9 B III\ 26.0 kg/m2, 26.0 B IV\ 45.1 kg/m2;
WC: 52 B I\ 77 cm, 77 B II\ 84 cm, 84 B III\ 90 cm,
90 B IV\ 137 cm; and WHR: 0.32 B I\ 0.46,
0.46 B II\ 0.50, 0.50 B III\ 0.53, 0.53 B IV\ 0.78. For
females, BMI: 13.2 B I\ 20.6 kg/m2, 20.6 B II\ 22.6 kg/
m2, 22.6 B III\ 25.1 kg/m2, 25.1 B IV\ 42.2 kg/m2;
WC: 55 B I\ 70 cm, 70 B II\ 76 cm, 76 B III\ 83 cm,
83 B IV\ 116 cm; and WHR: 0.34 B I\ 0.45,
0.45 B II\ 0.49, 0.49 B III\ 0.54, 0.54 B IV\ 0.75.
Urine albumin and creatinine concentrations were measured
in random urine samples using a turbidimetric immunoassay
and colorimetric method, respectively (Hitachi Automatic
Analyzer 7600). The ratio of urinary albumin to urinary cre-
atinine is reported as the albumin–creatinine ratio (uACR) in
mg/g creatinine. Albuminuria was defined as uACR C30 mg/
g Cr [17].
Statistical analysis
The weighted mean and standard error (SE), or proportion
(%) and SE of the general characteristics according to
hypertension status were calculated considering the com-
plex sampling design of the KNHANES. Continuous data
are expressed as means and SEs, and categorical data as
frequencies and SEs, as appropriate. We used Student’s
t test to compare continuous variables and the Chi-squared
test to compare categorical variables between groups. The
triglyceride and uACR values were log transformed to
improve the normality of the distributions. The uACR was
assigned a value of 1 mg/g in cases in which the urine
albumin level was below the detection threshold to allow
for log transformation. A multivariate logistic regression
was performed to estimate the adjusted odds ratio (OR) and
95 % confidence interval (CI) and assess the risk for
albuminuria according to the obesity indices. We adjusted
for age, lifestyle (smoking and physical activity), high BP,
and impaired fasting glucose and triglyceride levels in the
logistic regression analyses. All tests were two-sided, and
p\ 0.05 was considered to indicate significance. All
analyses were performed using PASW Statistics 21.0
(SPSS Inc., Chicago, IL, USA).
Results
General study subject characteristics according
to the presence of albuminuria
The sex-specific general characteristics of the study sub-
jects according to the presence of albuminuria are pre-
sented in Table 1. Mean age, BMI, WC, WHR, BP,
glucose, glycated hemoglobin, and triglyceride levels were
significantly higher in the albuminuria group than those in
the normoalbuminuria group in both sexes. A higher pro-
portion of female smokers was in the albuminuria group.
The prevalence of albuminuria was 3.5 % in the total study
population (4.2 % in females and 2.9 % in males).
Factors associated with albuminuria
Table 2 shows the ORs for albuminuria in the sex-specific
quartiles for the obesity indices and other potential con-
founders from the univariate logistic regression. Increased
age, BP, fasting glucose and triglyceride levels resulted in a
higher risk for albuminuria in both sexes. Current smoking
resulted in an increased risk for albuminuria in females
only. The second quartile group of all obesity indices was
used as the reference group, and the ORs for albuminuria in
each quartile group were calculated. The quartile group of
females for all obesity indices had an increased risk for
albuminuria compared to those in the second quartile
group. The ORs of the fourth quartile group for WC, WHR,
and BMI were 2.79 (95 % CI 1.51–5.16), 2.54 (95 % CI
1.38–4.67), and 2.63 (95 % CI 1.39–4.97). However, the
risk for albuminuria in males was not different between the
reference group and the other groups.
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ORs for albuminuria across sex-specific quartiles
of the obesity indices
Multivariate-adjusted ORs for albuminuria across sex-
specific quartiles of the obesity indices are shown in
Table 3. We adjusted for confounding variables, such as
age, smoking status, and physical activity, in models 1 and
2. The ORs of the fourth quartile group of all obesity
indices for females showed a significantly higher risk
compared to those in the reference group. However, the
risk for albuminuria in the fourth quartile group of WHR
lost significance (OR 1.84; 95 % CI 0.94–3.63) in model 3,
which was further adjusted for high BP and impaired
fasting glucose and triglyceride levels, whereas the fourth
quartile group of WC and BMI still showed a clear
increased risk for albuminuria (OR 1.96; 95 % CI
1.03–3.74 and OR 2.24; 95 % CI 1.15–4.37). Males tended
to show an increased risk of albuminuria according to their
WC and WHR, but the associations did not reach statistical
significance.
According to the subgroup analysis of the relationships
between each obesity index and albuminuria according to
the menopausal status of female subjects, we found that
those in the fourth quartile of postmenopausal women had
a significantly higher risk for albuminuria than did those in
the second quartile group according to their WC and BMI
(OR 2.47; 95 % CI 1.01–5.89 vs. OR 4.46; 95 % CI
1.66–11.95), whereas no such association was observed in
premenopausal women (supplementary Table A).
Table 1 Baseline characteristics of the study subjects according to the presence of albuminuria
Males (n = 1730) Females (n = 2111)
Normoalbuminuria Albuminuria P Normoalbuminuria Albuminuria P
Age (years) 40.67 (0.48) 50.26 (2.07) \0.001 42.76 (0.43) 49.2 (1.86) 0.001
Height (cm) 171.64 (0.23) 169.35 (0.72) 0.002 158.08 (0.18) 156 (0.86) 0.017
Weight (kg) 70.82 (0.39) 72.08 (2.27) 0.582 57.22 (0.28) 59.46 (1.16) 0.063
Body mass index (kg/m2) 23.99 (0.11) 25.04 (0.64) 0.108 22.90 (0.11) 24.35 (0.40) 0.001
Waist circumference (cm) 83.79 (0.35) 87.96 (1.85) 0.025 76.68 (0.27) 81.79 (1.18) \0.001
Waist-to-height ratio 0.489 (0.002) 0.519 (0.01) 0.002 0.486 (0.002) 0.525 (0.008) \0.001
Systolic BP (mmHg) 117.8 (0.44) 126.7 (2.20) \0.001 111 (0.42) 129.3 (3.08) \0.001
Diastolic BP (mmHg) 78.9 (0.34) 83.8 (1.47) 0.001 72.4 (0.27) 79.7 (1.46) \0.001
Pulse pressure 38.9 (0.27) 42.8 (1.68) 0.02 38.7 (0.28) 49.6 (2.17) \0.001
Hemoglobin A1c (%) 5.56 (0.02) 5.82 (0.10) 0.013 5.5 (0.01) 5.7 (0.08) 0.017
Fasting glucose (mmol/L) 94.4 (0.48) 103.2 (2.85) 0.003 90.9 (0.37) 96.6 (1.97) 0.005
Total cholesterol (mmol/L) 189.4 (1.33) 203.8 (4.52) 0.002 189.5 (0.95) 207.9 (4.08) \0.001
Triglyceride (mmol/L) 151.6 (3.95) 200.3 (17.5) 0.001 103.7 (1.99) 144 (8.44) \0.001
LDL-C (mmol/L) 115.1 (1.53) 115.9 (7.53) 0.918 111.8 (1.37) 128.7 (7.77) 0.032
HDL-C (mmol/L) 44.37 (0.72) 46.25 (5.91) 0.756 53.24 (0.74) 52.28 (4.25) 0.819
uACR (mg/g) 3.25 (0.14) 192.72 (62.67) \0.001 3.75 (0.13) 146 (35.7) \0.001
eGFR (ml/min/1.73 m2) 94.06 (0.54) 90.11 (1.94) 0.049 99.19 (0.60) 97.28 (2.45) 0.435
Smoker, n (%)
Never 20.8 (1.2) 19.9 (5.8) 0.687 85.1 (1.0) 74.3 (5.3) 0.023
Former 29.3 (1.5) 36.9 (8.9) 6.4 (0.7) 7.4 (2.8)
Current 47.8 (1.6) 42.1 (9.4) 6.5 (0.7) 15.7 (5.3)
Alcohol, n (%)
Never 3.8 (0.6) 6.5 (3.0) 0.435 11.6 (0.9) 15.6 (4.9) 0.510
Former 6.6 (0.8) 3.5 (2.0) 14.8 (1.0) 18 (5.1)
Current 87.5 (1.0) 89 (4.1) 71.7 (1.2) 63.8 (6.4)
Physical activity, n (%)
Inactive 76.6 (1.3) 73.3 (7.0) 0.619 81.8 (1.1) 86.9 (3.5) 0.222
Active 23.4 (1.3) 26.7 (7.0) 18.2 (1.1) 13.1 (3.5)
Data are mean ± standard error or an estimated percentage (standard error), as appropriate
LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, uACR urinary albumin-to-creatinine ratio, MDRD eGFR
modification of diet in renal disease estimated glomerular filtration rate
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Discussion
In this large nationally representative study, we demon-
strated an association between obesity and albuminuria in
non-diabetic, non-hypertensive females, but not in males.
Among various obesity indices in females, the highest
quartile WC and BMI groups had a twofold higher risk of
albuminuria than that in the reference group (second
quartile group) after adjusting for several potentially con-
founding factors. Our cutoff points for the highest WC and
BMI quartile to predict albuminuria were 83 cm and
25.1 kg/m2, respectively, which were similar to the obesity
thresholds used in another Asian population [18]. Although
none of the obesity indices was associated with albumin-
uria in Korean males, the risk for albuminuria tended to
increase with WC and WHR, but not BMI.
Several studies have reported that obesity is a risk factor
for the development and progression of CKD and albu-
minuria [19, 20]. Furthermore, systematic reviews suggest
that weight loss intervention is associated with improved
estimated glomerular filtration rate and albuminuria [21,
22]. Several possible mechanisms explain how obesity
increases the risk for albuminuria. First, adipose tissue is a
source of several active compounds, such as tumor necrosis
factor-a, interleukin-6, monocyte chemoattractant protein-
1, C-reactive protein, plasminogen activator inhibitor-1,
resistin, and free fatty acids. These adipokines cause renal
damage by inducing sympathetic overactivity, systemic
inflammation, and oxidative stress [20]. Second, adipocytes
secrete hormones, including adiponectin and leptin, which
regulate podocyte function. Decreasing serum adiponectin
and increasing serum leptin levels is a consistent feature
among obese patients and may induce microalbuminuria
[23]. Third, visceral obesity and associated insulin resis-
tance lead to hyperinsulinemia and activate the renin-an-
giotensin system, which can lead to glomerular
hypertension, endothelial dysfunction, vasoconstriction,
and matrix proliferation and expansion [4, 24].
Sex-specific associations were an important part of this
study. Previous studies have reported significant associa-
tions between obesity and CKD in males and females [7–9,
25]. However, several Asian studies have suggested sex-
specific associations between obesity and renal dysfunction
or albuminuria. Studies from Singapore and Japan show
that higher BMI is associated with CKD and proteinuria
only in males [10–12, 26]. In contrast, Chinese studies have
reported that abdominal obesity is related to CKD and
albuminuria only in females [13, 14], which was similar to
our results.
In this study, we first demonstrated sex-specific associ-
ations between obesity and albuminuria in the general
population. These associations were more prominent in
females, especially those who were postmenopausal, but
were not apparent in males. The reason for the insignificant
association between obesity and albuminuria in males is
unclear. Despite previous studies reporting that the male
sex is associated with a more rapid rate of progression of
renal disease [27], the prevalence of albuminuria in our
Table 2 Factors associated with albuminuria in the univariate
logistic regression
Males Females
OR (95 % CI) OR (95 % CI)
Age (years) 1.05 (1.03–1.07) 1.03 (1.02–1.05)
Systolic BP (mmHg) 1.04 (1.02–1.06) 1.05 (1.04–1.07)
Diastolic BP (mmHg) 1.05 (1.02–1.07) 1.08 (1.05–1.10)
High blood pressurea 3.08 (1.65–5.74) 6.29 (3.45–11.37)
Impaired fasting glucoseb 2.17 (1.15–4.07) 2.26 (1.24–4.13)
Triglyceride (mmol/L)
\1.69 1 1
1.69 to\2.26 1.46 (0.53–4.00) 2.98 (1.58–5.62)
2.26 to\5.65 3 (1.40–6.42) 2.61 (1.28–5.28)
C5.65 1.34 (0.36–5.07) 9.56 (1.58–58)
Waist circumference (cm)
I 0.59 (0.20–1.74) 0.75 (0.32–1.74)
II 1 1
III 1.37 (0.65–2.89) 0.63 (0.26–1.53)
IV 1.68 (0.66–4.29) 2.79 (1.51–5.16)
Waist-to-height ratio
I 0.51 (0.18–1.42) 0.48 (0.19–1.20)
II 1 1
III 0.95 (0.40–2.27) 1.22 (0.57–2.60)
IV 1.94 (0.78–4.83) 2.54 (1.38–4.67)
Body mass index (kg/m2)
I 0.55 (0.21–1.46) 0.89 (0.40–1.99)
II 1 1
III 0.66 (0.28–1.52) 1.44 (0.67–3.09)
IV 1.41 (0.56–3.52) 2.63 (1.39–4.97)
Smoking
Never 1 1
Former 1.32 (0.56–3.09) 1.32 (0.58–3.00)
Current 0.92 (0.39–2.15) 2.77 (1.25–6.15)
Alcohol
Never 1 1
Former 0.31 (0.08–1.22) 0.9 (0.37–2.16)
Current 0.6 (0.21–1.75) 0.66 (0.32–1.38)
Physical activity
Active 1 1
Inactive 0.84 (0.41–1.69) 1.47 (0.79–2.73)
CI confidence interval, OR odds ratio
a High blood pressure was defined as systolic blood pres-
sure C140 mmHg or diastolic blood pressure C90 mmHg
b Fasting blood glucose C5.55 mmol/L
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study was higher in females (4.2 %) than that in males
(2.9 %). Using the standardized uACR value of C30 mg/g
Cr to define microalbuminuria may underestimate
microalbuminuria in men, whereas it may overestimate it
in women, because the muscle mass and urinary excretion
of creatinine in women are usually lower than those in men
[28].
Table 3 Multivariate-adjusted
odds ratios for albuminuria
across sex-specific quartiles of
the obesity indices
Model 1a Model 2b Model 3c
OR (95% CI) OR (95% CI) OR (95% CI)
Males
WC
I 0.63 (0.22–1.86) 0.52 (0.17–1.61) 0.60 (0.19–1.86)
II 1 1 1
III 1.28 (0.61–2.70) 1.25 (0.58–2.69) 1.03 (0.45–2.34)
IV 1.71 (0.66–4.43) 1.74 (0.67–4.57) 1.28 (0.44–3.78)
P for trend 0.045 0.028 0.306
WHR
I 0.61 (0.21–1.72) 0.55 (0.18–1.65) 0.73 (0.24–2.22)
II 1 1 1
III 0.84 (0.35–2.01) 0.89 (0.36–2.16) 0.83 (0.33–2.05)
IV 1.70 (0.68–4.25) 1.81 (0.70–4.64) 1.43 (0.52–3.92)
P for trend 0.039 0.023 0.306
BMI
I 0.50 (0.19–1.28) 0.44 (0.16–1.19) 0.51 (0.19–1.34)
II 1 1 1
III 0.60 (0.26–1.39) 0.60 (0.26–1.40) 0.48 (0.20–1.16)
IV 1.69 (0.65–4.41) 1.76 (0.65–4.78) 1.26 (0.40–3.97)
P for trend 0.058 0.043 0.366
Females
WC
I 0.88 (0.37–2.05) 0.79 (0.33–1.93) 0.77 (0.30–2.00)
II 1 1 1
III 0.58 (0.24–1.38) 0.60 (0.24–1.46) 0.50 (0.20–1.25)
IV 2.44 (1.30–4.58) 2.29 (1.17–4.49) 1.96 (1.03–3.74)
P for trend 0.015 0.015 0.018
WHR
I 0.55 (0.22–1.37) 0.54 (0.21–1.36) 0.59 (0.23–1.56)
II 1 1 1
III 1.09 (0.51–2.35) 1.11 (0.51–2.41) 0.95 (0.43–2.10)
IV 2.19 (1.15–4.19) 2.12 (1.07–4.19) 1.84 (0.94–3.63)
P for trend 0.011 0.018 0.009
BMI
I 1.07 (0.47–2.46) 0.93 (0.39–2.19) 0.99 (0.40–2.41)
II 1 1 1
III 1.32 (0.61–2.83) 1.24 (0.56–2.75) 1.15 (0.54–2.49)
IV 2.58 (1.36–4.90) 2.40 (1.24–4.68) 2.24 (1.15–4.37)
P for trend 0.003 0.005 0.019
CI confidence interval, OR odds ratio, WC waist circumference, WHR waist-to-height ratio, BMI body mass
index
a Adjusted for age
b Adjusted for age, lifestyle (smoking and physical activity)
c Adjusted for age, lifestyle (smoking and physical activity), high blood pressure, and impaired fasting
glucose and triglyceride levels
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One possible reason for the sex difference in the asso-
ciation between obesity and albuminuria is that sex hor-
mones affect the kidneys and influence the progression of
renal disease, including mesangial proliferation, matrix
accumulation, activation of the rennin-angiotensin system,
and synthesis and release of cytokines [29, 30]. 17b-
Estradiol suppresses total collagen synthesis by mesangial
cells, whereas testosterone does not affect collagen syn-
thesis. In addition, estrogens may exert potent antioxidant
actions in the mesangium, which slows the development of
glomerulosclerosis and provide a protective effect against
the progression of renal disease in females [31]. This
finding suggests that sex could act as a renal disease
modifier. Because we excluded subjects with self-reports of
chronic renal disease, more females with slowly progress-
ing renal disease may have been included in our study.
Another possible reason is that the impact of potential
confounders on albuminuria may be greater than the
strength of the association with obesity in males. The
mechanism of how obesity affects renal damage by sex
should be clarified in future studies. In addition, the
abdominal obesity indices (WC and WHR), but not BMI,
tended to increase the risk for albuminuria in males.
Because BMI could not be stratified for muscle mass and
fat mass, subjects with higher muscle mass may have been
misclassified into the obese group.
Our study had several strengths. First, we used data from
a large nationally representative sample, which could
warrant generalizability. Second, we minimized the influ-
ences of traditional risk factors for CKD and focused on the
associations between obesity and albuminuria with respect
to sex. We selected a healthy population without hyper-
tension or diabetes, stratified according to sex, and adjusted
for a wide range of confounding factors. Despite these
strengths, there were limitations to this study. First, this
study had a cross-sectional design, which did not allow us
to make causal inferences. Second, we did not collect urine
samples or analyze 24-h urinary albumin excretion.
Instead, we used a single uACR result, which may have
misclassified some albuminuria cases. However, spot urine
uACR is commonly used to monitor kidney damage and
predict cardiovascular risk in clinical practice [32].
In this nationally representative study, we investigated
sex-specific associations between various obesity indices
(WC, WHR, and BMI) and albuminuria in the general
Korean population. We demonstrated a significant associ-
ation between obesity and albuminuria in females, but not
in males. Among women, a higher WC or BMI was sig-
nificantly associated with the risk for albuminuria. These
results provide putative evidence that obesity should be
considered an independent risk factor for albuminuria in
women, and future studies should clarify the mechanisms
underlying such sex differences.
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